Get this delivered to your inbox, and more info about our products and services.
At 95, Warren Buffett proves he’s still the sharpest dealmaker with $10 billion OxyChem deal
The transaction reflects Buffett's investment acumen: buying a good business at an attractive price, while skirting the possibility of costly headaches.






